Company profile
Aptadel Therapeutics
Aptadel Therapeutics is a biotech company focused on the development of cancer treatment based on aptamer technology.
- Industry
- Biotechnology Research
- Employees
- 11
- Headquarters
- Barcelona
- Founded
- 2020
- Office locations
- 1
Aptadel Therapeutics company summary
Aptadel Therapeutics is a company in the Biotechnology Research industry, headquartered in Barcelona, founded in 2020. On LinkedIn the company has around 11 employees. Its listed specialties include oncology, aptamer-drug conjugates, RNA therapeutics, pediatric.
What technology does Aptadel Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Aptadel Therapeutics
Aptadel Therapeutics, a spin-off from IDIBELL, was born from a deep commitment to advancing research in paediatric cancer, particularly Ewing sarcoma. Aptadel Therapeutics uses aptamers as a platform to deliver therapeutic agents with high specificity and improved safety to treat a wide variety of cancers. The company has expanded its vision and consolidated a robust platform to develop targeted therapies for both paediatric and adult cancers. We aim to bring the precision of aptamers across every stage of life, from paediatric oncology to highly aggressive adult cancers.
Specialties
Where is Aptadel Therapeutics located?
Aptadel Therapeutics lists 1 location.
Compare companies similar to Aptadel Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Aptadel Therapeutics aptadeltx.com | Biotechnology Research | 11 | 2020 | Barcelona |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Aptadel Therapeutics
What does Aptadel Therapeutics do?
Aptadel Therapeutics, a spin-off from IDIBELL, was born from a deep commitment to advancing research in paediatric cancer, particularly Ewing sarcoma. Aptadel Therapeutics uses aptamers as a platform to deliver therapeutic agents with high specificity and improved safety to treat a wide variety of cancers. The company has expanded its vision and consolidated a robust platform to develop targeted therapies for both paediatric and adult cancers. We aim to bring the precision of aptamers across every stage of life, from paediatric oncology to highly aggressive adult cancers.
How many employees does Aptadel Therapeutics have?
Aptadel Therapeutics has around 11 employees on LinkedIn.
Where is Aptadel Therapeutics headquartered?
Aptadel Therapeutics is headquartered in Barcelona.
When was Aptadel Therapeutics founded?
Aptadel Therapeutics was founded in 2020.
Build a lead list from companies like Aptadel Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.